To buy shares in CytoMed Therapeutics Limited you will need a US based stock trading platform like Interactive Brokers, eToro or Moomoo where it currently costs $1.78 to buy one share in CytoMed Therapeutics Limited (as of 14:04 18-Aug-2025). Which is a change of $0.02 or -1.11% from the last closing price of $1.8.
How To Buy CytoMed Therapeutics Limited Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in CytoMed Therapeutics Limited:
- Pick a stock broker (jump down to compare the best brokers for buying CytoMed Therapeutics Limited stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:GDTC)
- Choose the number of shares you want to buy (1 share currently costs $1.78)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your CytoMed Therapeutics Limited stock in your account (this will show your profit and loss)
- CytoMed Therapeutics Limited is currently worth $20,568,415 based on the last closing price of $1.8 with 20,949 shares traded.
- The most recent CytoMed Therapeutics Limited daily high has been $1.8 and daily low $1.77.
- The CytoMed Therapeutics Limited stock price 52 week high has been $4.05 and the 52 week low $1.2.
Compare Brokers For Buying CytoMed Therapeutics Limited Stock
It’s usually commission-free to buy US stocks as American stock brokers make their money from payment for order flow. However, there can sometimes be additional charges for buying stocks in an IRA, where your contributions are tax-deductible.
| US Stock Broker | US Stocks Available | Dealing Commission | Margin Rates | Customer Reviews | More Info |
|---|---|---|---|---|---|
 | 17,913 | 0.003% | 5.33% – 6.33% | (Based on 934 reviews)
| Visit Broker Your capital is at risk |
 | 6,000+ | 0% | 0% | (Based on 144 reviews)
| Visit Broker Your capital is at risk |
 | 5,000+ | 0% | 8% – 11% | (Based on 0 reviews)
| Read Reviews |
 | 4,000+ | 0% | 10.2% – 13.2% | (Based on 1 reviews)
| Read Reviews |
 | 4,000+ | 0% | 8.575% – 13.075% | (Based on 22 reviews)
| Read Reviews |
 | 5,000+ | 0% | 8% (Flat) | (Based on 23 reviews)
| Read Reviews |
 | 7,000+ | 0% | 8.5% – 12.075% | (Based on 0 reviews)
| Read Reviews |
 | 5,000+ | 0% | 9.49% (Flat) | (Based on 0 reviews)
| Read Reviews |
Is Now A Good Time To Buy CytoMed Therapeutics Limited Stock?
For expert analysis join Good Money Guide Premium.
- CytoMed Therapeutics Limited’s EPS (earnings per share) are 0.21. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- CytoMed Therapeutics Limited’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below CytoMed Therapeutics Limited share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.